Ali A. Asadi-Pooya, Michael R. Sperling

Antiseizure Medications (eBook, ePUB)

A Clinician's Manual

• Format: ePub

Produktbeschreibung

This new edition of Antiseizure Medications: A Clinician's Manual reflects the advances in the study and treatment of epilepsy in the past several years. As a practical tool for physicians and other healthcare providers, this text focuses on the selection and use of antiseizure medications in a variety of clinical contexts. In the past decade, many new antiseizure medications (ASMs) have been introduced, so that there are now approximately 30 medications available to treat epilepsy. The healthcare provider therefore has many choices. However, having many alternatives also allows for the possibility of choosing an inappropriate or a suboptimal agent. The choice of medication should be guided by knowledge and familiarity with the ASMs. In this new edition, the authors discuss choosing drugs when faced with various medical comorbidities; how to correctly prescribe, titrate, and taper drugs; how to monitor drug efficacy and side effects; how to diagnose and manage toxicity; interactions with other drugs; and other relevant issues. With updated references, terminology, materials, and drugs, this third edition meets the needs of clinicians who must treat their patients living with epilepsy.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Oxford University Press
• Erscheinungstermin: 16. September 2022
• Englisch
• ISBN-13: 9780197541234
• Artikelnr.: 65975229

Autorenporträt

Ali A. Asadi-Pooya, M.D. Professor of Epileptology Director, Epilepsy Research Center, Shiraz University of Medical Sciences Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University Michael R. Sperling, MD Baldwin Keyes Professor of Neurology Director, Jefferson Comprehensive Epilepsy Center Vice Chair for Research, Department of Neurology, Thomas Jefferson University

Inhaltsangabe

* 1. Diagnosis and Evaluation of Patients With Seizures
* 2. Antiseizure Medications Dosage Forms and Administration Guidelines
* 3. Mechanisms of Action and Pharmacokinetic Properties of Antiseizure
Medications
* 4. Monitoring Antiseizure Medications and Their Toxicity
* 5. Choices of Antiseizure Medications Based on Specific Epilepsy
Syndromes and Seizure Types
* 6. Clinically Important Drug Interactions With Antiseizure
Medications
* 7. Aggravation of Seizures by Antiseizure Medications
* 8. Polytherapy With Antiseizure Medications
* 9. Antiseizure Medications in Pregnancy
* 10. Antiseizure Medications in Lactating Women
* 11. Antiseizure Medications in the Elderly
* 12. Antiseizure Medications in Patients With Renal Disease
* 13. Antiseizure Medications in Patients With Liver Disease
* 14. Antiseizure Medications and Metabolic Disorders
* 15. Antiseizure Medications in Patients With Hyperlipidemia
* 16. Antiseizure Medications in Patients With Diabetes Mellitus
* 17. Antiseizure Medications in Patients With Cardiovascular Disorders
* 18. Antiseizure Medications in Patients With Hematological Disorders
* 19. Antiseizure Medications in Patients on Chemotherapy or
Immunosuppressive Therapy
* 20. Antiseizure Medications in Patients with Brain Tumors
* 21. Antiseizure Medications in Patients With Stroke
* 22. Antiseizure Medications in Patients With Multiple Sclerosis
* 23. Antiseizure Medications in Patients With Preexisting Psychiatric
Problems
* 24. Antiseizure Medications and Cognition
* 25. Antiseizure Medications in Patients With Migraine Headaches
* 26. Antiseizure Medications in Patients With Neuropathic Pain
Syndromes
* 27. Antiseizure Medications and Cutaneous Reactions
* 28. Antiseizure Medications and Ophthalmologic Problems
* 29. Antiseizure Medications and Weight Change
* 30. Antiseizure Medications and Bone Health
* 31. Antiseizure Medications in Patients With HIV Infection/AIDS
* 32. Antiseizure Medications in Patients With Coronavirus Infections
* 33. Antiseizure Medications in the Pipeline